Michael David M.d. Katz serves as Executive at Hanover Bancorp, Inc. /NY, where they oversee executive responsibilities. Since joining the company, Michael David M.d. Katz has executed 8 insider transactions totaling $118.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 5, 2026 involved receiving (via award) 1,592 shares valued at $0.
Michael David M.d. Katz currently holds 152,202 shares of Hanover Bancorp, Inc. /NY (HNVR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael David M.d. Katz has been a net buyer of HNVR stock. They have purchased $118.9K and sold $0 worth of shares.
Michael David M.d. Katz's most recent insider trade was on Feb 5, 2026, when they sold 1,592 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $10.00 |
| Discretionary |
| Mar 1, 2024 | HNVR | $0 | Award | 2,117 | $N/A | Discretionary |
| Jan 29, 2024 | HNVR | $12.6K | Purchase | 700 | $18.02 | Discretionary |
| Jan 24, 2023 | HNVR | $0 | Award | 1,612 | $N/A | Discretionary |
| Aug 12, 2022 | HNVR | $804 | Purchase | 40 | $20.11 | Discretionary |
| Aug 11, 2022 | HNVR | $500 | Purchase | 25 | $19.99 | Discretionary |
| May 11, 2022 | HNVR | $105.0K | Purchase | 5,000 | $21.00 | Discretionary |